Pradeep Chaluvally-Raghavan, PhD

Publications

• Targeted biologic inhibition of both tumor cell-intrinsic and intercellular CLPTM1L/CRR9-mediated chemotherapeutic drug resistance.

  (Parashar D, Geethadevi A, McAllister D, Ebben J, Peterson FC, Jensen DR, Bishop E, Pradeep S, Volkman BF, Dwinell MB, Chaluvally-Raghavan P, James MA.) NPJ Precis Oncol. 2021 Mar 02;5(1):16 PMID: 33654182 PMCID: PMC7925570 03/04/2021

• Peritoneal Spread of Ovarian Cancer Harbors Therapeutic Vulnerabilities Regulated by FOXM1 and EGFR/ERBB2 Signaling.

  (Parashar D, Nair B, Geethadevi A, George J, Nair A, Tsaih SW, Kadamberi IP, Gopinadhan Nair GK, Lu Y, Ramchandran R, Uyar DS, Rader JS, Ram PT, Mills GB, Pradeep S, Chaluvally-Raghavan P.) Cancer Res. 2020 12 15;80(24):5554-5568 PMID: 33087324 PMCID: PMC7744365 SCOPUS ID: 2-s2.0-85100331032 10/23/2020

• Emerging Role of Extracellular Vesicles in Immune Regulation and Cancer Progression.

  (Mittal S, Gupta P, Chaluvally-Raghavan P, Pradeep S.) Cancers (Basel). 2020 Nov 28;12(12) PMID: 33260606 PMCID: PMC7760253 SCOPUS ID: 2-s2.0-85096847824 12/03/2020

• Anticancer effect of physical activity is mediated by modulation of extracellular microRNA in blood.

  (Pulliero A, You M, Chaluvally-Raghavan P, Marengo B, Domenicotti C, Banelli B, Degan P, Molfetta L, Gianiorio F, Izzotti A.) Oncotarget. 2020 Jun 02;11(22):2106-2119 PMID: 32547708 PMCID: PMC7275780 06/18/2020

• ERBB3-induced furin promotes the progression and metastasis of ovarian cancer via the IGF1R/STAT3 signaling axis.

  (Chen C, Gupta P, Parashar D, Nair GG, George J, Geethadevi A, Wang W, Tsaih SW, Bradley W, Ramchandran R, Rader JS, Chaluvally-Raghavan P, Pradeep S.) Oncogene. 2020 04;39(14):2921-2933 PMID: 32029900 PMCID: PMC7346970 SCOPUS ID: 2-s2.0-85079196544 02/08/2020

• Anticancer effect of physical activity is mediated by modulation of extracellular microRNA in blood

  (Pulliero A, You M, Chaluvally-Raghavan P, Marengo B, Domenicotti C, Banelli B, Degan P, Molfetta L, Gianiorio F, Izzotti A.) Oncotarget. 1 June 2020;11(22):2106-2119 SCOPUS ID: 2-s2.0-85090283897 06/01/2020

• miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast Cancer.

  (Parashar D, Geethadevi A, Aure MR, Mishra J, George J, Chen C, Mishra MK, Tahiri A, Zhao W, Nair B, Lu Y, Mangala LS, Rodriguez-Aguayo C, Lopez-Berestein G, Camara AKS, Liang M, Rader JS, Ramchandran R, You M, Sood AK, Kristensen VN, Mills GB, Pradeep S, Chaluvally-Raghavan P.) Cell Rep. 2019 12 24;29(13):4389-4406.e10 PMID: 31875548 PMCID: PMC7380555 SCOPUS ID: 2-s2.0-85076674271 12/26/2019

• B Cells as an Immune-Regulatory Signature in Ovarian Cancer.

  (Gupta P, Chen C, Chaluvally-Raghavan P, Pradeep S.) Cancers (Basel). 2019 Jun 26;11(7) PMID: 31248034 PMCID: PMC6678944 SCOPUS ID: 2-s2.0-85068665327 06/30/2019

• Interaction of tumor cells and astrocytes promotes breast cancer brain metastases through TGF-β2/ANGPTL4 axes.

  (Gong X, Hou Z, Endsley MP, Gronseth EI, Rarick KR, Jorns JM, Yang Q, Du Z, Yan K, Bordas ML, Gershan J, Deepak P, Geethadevi A, Chaluvally-Raghavan P, Fan Y, Harder DR, Ramchandran R, Wang L.) NPJ Precis Oncol. 2019;3:24 PMID: 31602400 PMCID: PMC6776663 10/12/2019

• ERBB signaling in CTCs of ovarian cancer and glioblastoma.

  (Geethadevi A, Parashar D, Bishop E, Pradeep S, Chaluvally-Raghavan P.) Genes Cancer. 2017 Nov;8(11-12):746-751 PMID: 29321816 PMCID: PMC5755720 SCOPUS ID: 2-s2.0-85042923599 01/13/2018

• miRNA-Mediated RNA Activation in Mammalian Cells.

  (Ramchandran R, Chaluvally-Raghavan P.) Adv Exp Med Biol. 2017;983:81-89 PMID: 28639193 SCOPUS ID: 2-s2.0-85021314316 06/24/2017

• Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer.

  (Chaluvally-Raghavan P, Jeong KJ, Pradeep S, Silva AM, Yu S, Liu W, Moss T, Rodriguez-Aguayo C, Zhang D, Ram P, Liu J, Lu Y, Lopez-Berestein G, Calin GA, Sood AK, Mills GB.) Cell Rep. 2016 05 17;15(7):1493-1504 PMID: 27160903 PMCID: PMC4914391 SCOPUS ID: 2-s2.0-84964941322 05/11/2016